Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CMSQY | DOCN |
|---|---|---|
| Price | $27.84 | $137.23 |
| Change today | ▼ 0.18% | ▼ 2.03% |
| Market cap | $16.13B | $16.14B |
| Return, 3 months | +6.9% | +0.1% |
| Return, year to date | +29.2% | +185.2% |
| Return, 1 year | +21.7% | +257.5% |
| P/E (TTM) | 26.0 | 62.4 |
| P/B | 7.0 | 17.3 |
| P/E percentile vs own 5y | – | 87th |
| Dividend yield | 3.31% | – |
| Revenue growth (YoY, latest qtr) | – | +28.6% |
| Net profit growth (YoY) | – | -4.3% |
| Gross margin | – | 57.2% |
| Operating margin | – | 14.8% |
| Net margin | – | 23.3% |
| Return on equity | – | 62.3% |
| Analyst target vs. price | – | +28.3% |
| Analyst buy share | – | 86% |
| RSI (14) | 44 | 55 |
| 30-day volatility | 31.8% | 74.7% |
| Max drawdown, 1 year | -21.9% | -42.2% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
